Metronidazole Use in Pregnancy

Trimester-Specific Recommendations

The Centers for Disease Control and Prevention recommends oral metronidazole is safe and recommended for appropriate indications after the first trimester 1, 2, 3
The American College of Gastroenterology suggests metronidazole 250 mg orally three times daily for 7 days is the recommended regimen for bacterial vaginosis in pregnancy 1
Alternative regimen: metronidazole 500 mg twice daily for 7 days is recommended by the Centers for Disease Control and Prevention 1

The Centers for Disease Control and Prevention recommends all symptomatic pregnant women should be tested and treated for bacterial vaginosis 1
Bacterial vaginosis is associated with premature rupture of membranes, chorioamnionitis, preterm labor, preterm birth, postpartum endometritis, and post-cesarean wound infection, according to the Centers for Disease Control and Prevention 1
High-risk pregnant women should be screened and treated at the first prenatal visit to potentially reduce preterm delivery, as recommended by the Centers for Disease Control and Prevention 1

The American Gastroenterological Association suggests metronidazole can be given for pouchitis, perianal Crohn's disease, or intra-abdominal abscesses from fistulizing Crohn's disease 2, 3

Multiple studies and meta-analyses have not demonstrated a consistent association between metronidazole use during pregnancy and teratogenic or mutagenic effects, according to the Centers for Disease Control and Prevention 1

The Centers for Disease Control and Prevention recommends lower doses are recommended during pregnancy to minimize fetal exposure 4, 1
The benefits of treating symptomatic infections typically outweigh theoretical risks, especially after the first trimester, as suggested by the Centers for Disease Control and Prevention and the American Gastroenterological Association 1, 2

The Centers for Disease Control and Prevention recommends routine treatment of sex partners is not recommended for bacterial vaginosis 4
For trichomoniasis, treating sex partners increases cure rates, according to the Centers for Disease Control and Prevention 4

Topical metronidazole (0.75-1%) is safe throughout all trimesters due to significantly lower systemic absorption compared to oral administration, as recommended by the American Academy of Dermatology for rosacea treatment 5
The American Academy of Dermatology recommends topical metronidazole as mainstay therapy for rosacea during pregnancy, with both 0.75% and 1.0% formulations showing similar efficacy 5

The American College of Obstetricians and Gynecologists notes traditional concerns about first trimester use, though meta-analyses do not indicate teratogenicity in humans 6
Clindamycin vaginal cream 2% is preferred as first-line treatment for bacterial vaginosis in the first trimester, with one full applicator intravaginally at bedtime for 7 days 6
The CDC recommends oral metronidazole 250 mg three times daily for 7 days as a treatment option during the second and third trimesters 6

Bacterial vaginosis is associated with adverse pregnancy outcomes including premature rupture of membranes, preterm labor, and preterm birth, according to the American College of Obstetricians and Gynecologists 6
Treatment of bacterial vaginosis in high-risk pregnant women may reduce the risk of preterm delivery, as suggested by the American College of Obstetricians and Gynecologists 6
Long-term maternal therapy could theoretically risk neonatal bleeding by inhibiting vitamin K synthesis, and the European Respiratory Society recommends treating mother and neonate with phytomenadione (vitamin K) if prolonged therapy is used 7
If a single 2g oral dose is used during lactation, the European Respiratory Society recommends stopping breastfeeding for 12-24 hours after the dose 7

The Centers for Disease Control and Prevention (CDC) historically advised avoiding oral metronidazole during the first trimester because the recommendation was based on precautionary animal‑study data rather than human evidence. 8

For pregnant patients after the first trimester, a single 2 g oral dose of metronidazole is recommended to treat trichomoniasis. 8

Prolonged maternal metronidazole therapy may theoretically increase the risk of neonatal bleeding by inhibiting vitamin K synthesis; when long‑term treatment is required, both mother and newborn should receive vitamin K (phytomenadione) prophylaxis. 9

If a single 2 g oral dose of metronidazole is administered to a lactating mother, breastfeeding should be withheld for 12–24 hours after the dose. 9
For standard metronidazole dosing regimens during lactation, breastfeeding is generally compatible and does not require interruption. 9